The Biopolymer Resource provides advice and technical services to RPCI staff in DNA sequencing, synthesis, and characterization of oligonucleotides and peptides; the isolation, purification and characterization of proteins and peptides; mass spectrometry of synthetic organics, drug and drug metabolites (pharmacokinetic studies); and peptides and proteins (proteomics). The Biopolymer Resource supports the staff in developing and understanding the uses and applications of the various services provided ensuring convenient access to these and related technical services. To accommodate the evolving research needs and interests of RPCI faculty and to support the technical requirements of their projects, the Biopolymer Resource continually evaluates and implements new methodologies and acquires new instruments. The facility is heavily used by CCSG members. In 2001-2002, the Biopolymer Resource provided services to over 60 investigators from all five CCSG Programs, who collectively hold over $13.8M in peer-reviewed funding. The technical services offered by the Resource have increased and diversified, and as a result of the newly recruited faculty, further increases in Resource utilization are anticipated. Information regarding services is disseminated through seminar series and CCSG program and workshop meetings. The Strategic Plan is to continue to provide contemporary technical services and assistance to the CCSG Program members with peer-reviewed funding. An area that has been targeted for further development is that of proteomics, particularly as it relates to the use and applications of mass spectrometry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-31
Application #
7417847
Study Section
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
31
Fiscal Year
2007
Total Cost
$161,883
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Tubbs, Anthony; Sridharan, Sriram; van Wietmarschen, Niek et al. (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell 174:1127-1142.e19

Showing the most recent 10 out of 1555 publications